Roche rings Bicycle bell again, grabbing another cancer targ...

Roche's Genentech unit has gone all in on its collaboration with UK biotech Bicycle Therapeutics, taking up an option on a second additional target in the area of cancer immunotherapy.

Roche hops on Bicycle’s drug discovery platform for cancer

Bicycle Therapeutics picks up speed with £40m fundraising

First-in-class compound set to enter phase 1 trials later this year

Bicycle Therapeutics signs cancer development deal with CRUK

Second deal in weeks for innovative peptides-focused biotech